| scholarly article | Q13442814 |
| P50 | author | Joellen M Schildkraut | Q61822968 |
| P2093 | author name string | Ricardo M Richardson | |
| Stephen J Freedland | |||
| Cathrine Hoyo | |||
| Delores J Grant | |||
| Elizabeth Calloway | |||
| Leah Gerber | |||
| Megan McPhail | |||
| Alexis R Gaines | |||
| Jonathan N Livingston | |||
| Katie Shuler | |||
| Shannon D Oliver | |||
| P2860 | cites work | Cancer statistics, 2012 | Q27860574 |
| A polymorphism in the UDP-Glucuronosyltransferase 2B15 gene (D85Y) is not associated with prostate cancer risk | Q28217523 | ||
| Association between polymorphisms in HSD3B1 and UGT2B17 and prostate cancer risk | Q28247271 | ||
| UDP-glucuronosyltransferase 2B15 (UGT2B15) and UGT2B17 enzymes are major determinants of the androgen response in prostate cancer LNCaP cells | Q28248233 | ||
| Isolation and characterization of UGT2B15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene | Q28248700 | ||
| Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men | Q28256609 | ||
| Genetic variation of genes involved in dihydrotestosterone metabolism and the risk of prostate cancer | Q28269652 | ||
| Large differences in testosterone excretion in Korean and Swedish men are strongly associated with a UDP-glucuronosyl transferase 2B17 polymorphism | Q28285412 | ||
| Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members | Q31836858 | ||
| Hormones and prostate cancer: what's next? | Q34393202 | ||
| A novel polymorphism in a forkhead box A1 (FOXA1) binding site of the human UDP glucuronosyltransferase 2B17 gene modulates promoter activity and is associated with altered levels of circulating androstane-3α,17β-diol glucuronide | Q39680659 | ||
| Exercise and prostate cancer risk in a cohort of veterans undergoing prostate needle biopsy | Q39900633 | ||
| Valproic acid induces neuroendocrine differentiation and UGT2B7 up-regulation in human prostate carcinoma cell line | Q40157030 | ||
| Inactivation by UDP-glucuronosyltransferase enzymes: the end of androgen signaling | Q42435837 | ||
| Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score | Q44830851 | ||
| Asp85tyr polymorphism in the udp-glucuronosyltransferase (UGT) 2B15 gene and the risk of prostate cancer | Q44883507 | ||
| Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers. | Q46013996 | ||
| Differential expression of the androgen-conjugating UGT2B15 and UGT2B17 enzymes in prostate tumor cells during cancer progression. | Q50985272 | ||
| Evaluation of Genetic Variations in the Androgen and Estrogen Metabolic Pathways as Risk Factors for Sporadic and Familial Prostate Cancer | Q57540169 | ||
| The Uridine Diphosphate Glucuronosyltransferase 2B15 D85Y and 2B17 Deletion Polymorphisms Predict the Glucuronidation Pattern of Androgens and Fat Mass in Men | Q57606345 | ||
| Correlation between circulatory, local prostatic, and intra-prostatic androgen levels | Q62835767 | ||
| Deletions of the Androgen-MetabolizingUGT2BGenes Have an Effect on Circulating Steroid Levels and Biochemical Recurrence after Radical Prostatectomy in Localized Prostate Cancer | Q62835790 | ||
| Transcriptional diversity at the UGT2B7 locus is dictated by extensive pre-mRNA splicing mechanisms that give rise to multiple mRNA splice variants | Q62835858 | ||
| Copy-number variations (CNVs) of the human sex steroid metabolizing genesUGT2B17andUGT2B28and their associations with aUGT2B15functional polymorphism | Q62836032 | ||
| Characterization of a common deletion polymorphism of the UGT2B17 gene linked to UGT2B15 | Q63951729 | ||
| An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer | Q73326232 | ||
| Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate | Q80044422 | ||
| Serum sex steroid hormones and lower urinary tract symptoms in Third National Health and Nutrition Examination Survey (NHANES III) | Q80185157 | ||
| The UGT2B17 gene deletion is not associated with prostate cancer risk | Q80626180 | ||
| The UGT2B17 gene deletion polymorphism and risk of prostate cancer. A case-control study in Caucasians | Q81439573 | ||
| P433 | issue | 1 | |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 3-9 | |
| P577 | publication date | 2012-10-25 | |
| P1433 | published in | Genetic Testing and Molecular Biomarkers | Q15753742 |
| P1476 | title | Association of uridine diphosphate-glucuronosyltransferase 2B gene variants with serum glucuronide levels and prostate cancer risk | |
| P478 | volume | 17 |
| Q64110801 | Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women |
| Q38717288 | Genetic polymorphisms of human UDP-glucuronosyltransferase (UGT) genes and cancer risk. |
| Q35078297 | Genetic variation in UGT genes modify the associations of NSAIDs with risk of colorectal cancer: colon cancer family registry |
| Q91796696 | Host factors influence Barrett's carcinogenesis: findings from a mouse gastroduodenal reflux model |
| Q46157943 | Intracrine androgen biosynthesis, metabolism and action revisited |
| Q35051456 | Novel associations of UDP-glucuronosyltransferase 2B gene variants with prostate cancer risk in a multiethnic study |
| Q42013762 | Nuclear Receptor Corepressor 1 Expression and Output Declines with Prostate Cancer Progression |
| Q62835509 | Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications |
| Q37142561 | Phase two steroid metabolism and its roles in breast and prostate cancer patients |
| Q36367643 | Uridine diphosphate-glucuronosyltransferase 2B15 D85Y gene polymorphism is associated with lower prostate cancer risk: a systematic review and meta-analysis |
Search more.